Mastering Stress and Improving Resilience During Times of Adversity

Date: Wednesday, January 27, 2021
Time: 1:00 PM – 2:00 PM EST
Duration: 60 minutes

STRESS!! It’s a key driver of all aspects of your mental health.  This webinar provides a practical framework and training pathway to measure and master stress, negativity and resilience. It focuses on the most recent evidence of what it takes to wire your brain’s optimal effectiveness.  How can we begin to reframe, and master, stress to build resilience and improve your personal and work life?  It also explores the employer’s role in helping to enhance stress mastery and boost resilience. We will discuss these very topics with Dr. Evian Gordon, MD, PhD – Founder, Chairman and Chief Medical Officer at Total Brain and Founder of the largest international database on the human brain.

Register Now

Audience:

HR Leaders, Wellness and Benefits Managers and Talent Development Leaders interested in understanding the impact of stress on mental health and performance, how to better manage stress, and ways to monitor and support your workforce in stressful times.

Key take-aways:

• Identify the impact stress has on the core brain capacities that define mental health
• Develop “in the moment” training to switch from a safety first, fight/flight state, to a calm, flexible state
• Define resilience and understand the key factors to bounce back from adversity
• Identify what employers can do to help their workers reduce stress and improve resilience

Meet The Presenter

Evian Gordon, PhD, MD, is the Executive Chairman and Chief Medical Officer of Total Brain. He established an “Integrative Neuroscience” approach, grounded in the use of standardized methods across multiple types of brain data in a single platform, with over a million data sets. He founded the Brain Resource Company that created the first standardized international database on the human brain (over 300 publications). The database is the asset which shaped Total Brain for mental health, and is used in over 30 Fortune 500 Companies by over 750,000 employees. The first genetics test using this methodology (in 1,700 patients) for treatment prediction in depression is currently being completed for potential use in clinical practice. He has published over 300 scientific papers and three books.